NCT06173804

Brief Summary

The purpose of this study is to explore strategies to effectively implement senior-center-based multilevel lifestyle interventions adapted from evidence-based lifestyle interventions to promote physical function and quality of life in diverse older adults with Type 2 Diabetes (T2D).

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
20

participants targeted

Target at below P25 for not_applicable type-2-diabetes

Timeline
Completed

Started Jul 2024

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 29, 2023

Completed
19 days until next milestone

First Posted

Study publicly available on registry

December 18, 2023

Completed
7 months until next milestone

Study Start

First participant enrolled

July 22, 2024

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 23, 2025

Completed
11 months until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2026

Completed
Last Updated

November 12, 2025

Status Verified

November 1, 2025

Enrollment Period

10 months

First QC Date

November 29, 2023

Last Update Submit

November 10, 2025

Conditions

Keywords

Evidence based lifestyle interventionOlder AdultsPhysical FunctionGlycemic control

Outcome Measures

Primary Outcomes (2)

  • Feasibility of conducting study

    Feasibility refers to how feasible to conduct the study. In this study, feasibility will be assessed by data such as participant recruitment, enrollment, education session attendance, and retention rate.

    Baseline, 3, 6, and 12 months

  • Acceptability

    Acceptability refers to how well an intervention will be received by the target population and the extent to which an intervention might meet the needs of the target population. Acceptability will be assessed through qualitative interview with participants to explore their experience, and perceptions with the intervention.

    Baseline, 3, 6, and 12 months

Secondary Outcomes (9)

  • Body Weight

    Baseline, 3, 6, and 12 months

  • Systolic Blood Pressure

    Baseline, 3, 6, and 12 months

  • Diastolic Blood Pressure

    Baseline, 3, 6, and 12 months

  • Short Physical Performance Battery (SPPB)

    Baseline, 3, 6, and 12 months

  • Grip Strength

    Baseline, 3, 6, and 12 months

  • +4 more secondary outcomes

Study Arms (1)

Lifestyle intervention group

EXPERIMENTAL

The study team will assess improvements in physical function assessed by the short physical performance battery and other health-related measures (diabetes knowledge, self-efficacy, social support, physical activity, diet consumption, HbA1c, and quality of life).

Other: Adapted Look Ahead Lifestyle Intervention

Interventions

Participants will be educated about improving healthy lifestyles involving physical activity and healthy eating to improve physical function and improve glycemic control.

Also known as: Multilevel Lifestyle Intervention
Lifestyle intervention group

Eligibility Criteria

Age60 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adults aged ≥60 years
  • Self-reported T2D diagnosis with verification from a health report
  • Live within the census tract of the selected senior center, or a member of the senior center
  • No significant cognitive impairment as defined by MMSE (score≥20) (46) which may influence diabetes self-management
  • Can speak and understand either English or Spanish
  • Agree to participate in the study procedures

You may not qualify if:

  • Severe chronic conditions without physician's permission to participate (e.g., severe heart disease and end-stage renal disease);
  • Unwillingness to sign the consent form; and
  • Enrollment in other diabetes management programs

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University Health System Texas Diabetic Institute

San Antonio, Texas, 78207, United States

Location

MeSH Terms

Conditions

Diabetes Mellitus, Type 2

Condition Hierarchy (Ancestors)

Diabetes MellitusGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System Diseases

Study Officials

  • Yan Du, PhD, MPH

    The University of Texas Health Science Center at San Antonio

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
SINGLE GROUP
Model Details: A pre-post-test study to assess the implementation outcomes and preliminary health responses
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 29, 2023

First Posted

December 18, 2023

Study Start

July 22, 2024

Primary Completion

May 23, 2025

Study Completion

May 1, 2026

Last Updated

November 12, 2025

Record last verified: 2025-11

Data Sharing

IPD Sharing
Will share

The deidentified quantitative data from the 15 participants such as demographics and clinical data could be shared upon request from the applicant after the study findings have been published in peer-reviewed journals. The biospecimen collected at the senior center will be transported to the School of Nursing Biobehavioral Laboratory by the laboratory staff or the PI in a dry ice container on the same day of data collection.

Shared Documents
STUDY PROTOCOL, SAP, ICF
Time Frame
Data may be shared after peer-reviewed journal publication after study completion or as summary results on ClinicalTrials.gov

Locations